ImageneBio (IMA) EPS (Basic) (QoQ) (2020 - 2025)
ImageneBio (IMA) EPS (Basic) (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | ImageneBio | 48.35 Mn | -87.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -104.28% |
| Jun 30, 2025 | 35.19% |
| Mar 31, 2025 | 47.77% |
| Dec 31, 2024 | -182.77% |
| Sep 30, 2024 | 62.85% |
| Jun 30, 2024 | 12.42% |
| Mar 31, 2024 | 16.40% |
| Dec 31, 2023 | -17.93% |
| Sep 30, 2023 | 8.34% |
| Jun 30, 2023 | -11.07% |
| Mar 31, 2023 | 10.52% |
| Dec 31, 2022 | 98.49% |
| Sep 30, 2022 | 51.15% |
| Jun 30, 2022 | -9,375.75% |
| Mar 31, 2022 | 42.55% |
| Dec 31, 2021 | 20.91% |
| Sep 30, 2021 | 8.82% |
| Jun 30, 2021 | 95.21% |
| Mar 31, 2021 | -176.90% |
| Dec 31, 2020 | -386.12% |